Evaluation of a novel immunoassay to detect p-tau Thr217 in the CSF to distinguish Alzheimer disease from other dementias.
Jozef HanesAndrej KovacHlin KvartsbergEva KontsekovaLubica FialovaStanislav KatinaBranislav KovacechEva StevensJakub HortMartin VyhnalekLynn BoonkampMichal NovakHenrik ZetterbergOskar HanssonPhilip ScheltensKaj BlennowCharlotte E TeunissenNorbert ZilkaPublished in: Neurology (2020)
This study provides Class III evidence that a CSF immunoassay for p-tau T217 distinguishes patients with AD from patients with other dementias and healthy controls.